ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 172 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2015. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $409,000 | -65.1% | 9,566 | -65.0% | 0.02% | -66.1% |
| Q3 2019 | $1,171,000 | -53.5% | 27,366 | -42.1% | 0.06% | -53.9% |
| Q3 2017 | $2,516,000 | +952.7% | 47,245 | +1289.6% | 0.13% | +814.3% |
| Q4 2016 | $239,000 | -38.6% | 3,400 | -44.7% | 0.01% | -17.6% |
| Q1 2016 | $389,000 | +13.7% | 6,153 | +101.5% | 0.02% | +6.2% |
| Q4 2015 | $342,000 | -81.9% | 3,053 | -83.5% | 0.02% | -74.6% |
| Q2 2015 | $1,893,000 | – | 18,493 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 217,459 | $24,760,000 | 1.64% |
| Motley Fool Asset Management LLC | 152,326 | $17,344,000 | 1.25% |
| Rock Springs Capital Management LP | 450,000 | $51,237,000 | 1.12% |
| AtonRa Partners | 21,017 | $2,393,000 | 1.07% |
| SECTORAL ASSET MANAGEMENT INC | 112,200 | $12,775,000 | 0.97% |
| EMERALD ADVISERS, LLC | 228,368 | $26,002,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 239,023 | $27,215,000 | 0.90% |
| FEDERATED HERMES, INC. | 3,912,408 | $445,467,000 | 0.86% |
| HealthCor Management, L.P. | 207,610 | $23,638,000 | 0.84% |
| Atika Capital Management LLC | 66,000 | $7,515,000 | 0.65% |